Skip to main content
Review

Clinical and economic impacts of explicit tools detecting prescribing errors: a systematic review.

Farhat A, Al-Hajje A, Csajka C, et al. Clinical and economic impacts of explicit tools detecting prescribing errors: a systematic review. J Clin Pharm Ther. Epub 2021 Mar 26. doi: 10.1111/jcpt.13408

Save
Print
May 26, 2021
Farhat A, Al‐Hajje A, Csajka C, et al. J Clin Pharm Ther. 2021;46(4):877-886.

Several tools have been developed to reduce potentially inappropriate prescribing. This study explored the economic and clinical impacts of two tools, STOPP/START and FORTA (Fit fOR The Aged list). Randomized controlled trials (RCTs) using those tools demonstrated significant clinical and economic impact in geriatric and internal medicine. Due to the low number of RCT studies evaluating these tools, additional studies are warranted.

Save
Print
Cite
Citation

Farhat A, Al-Hajje A, Csajka C, et al. Clinical and economic impacts of explicit tools detecting prescribing errors: a systematic review. J Clin Pharm Ther. Epub 2021 Mar 26. doi: 10.1111/jcpt.13408